...
首页> 外文期刊>Biochemical Pharmacology >S9788 modulation of P-glycoprotein- and Multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells.
【24h】

S9788 modulation of P-glycoprotein- and Multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells.

机译:Servier 9788在耐阿霉素的MCF7细胞中通过S9788调节P-糖蛋白和多种药物相关的蛋白质介导的多重药物耐药性。

获取原文
获取原文并翻译 | 示例

摘要

Inherent or acquired resistance to multiple natural drugs, termed multidrug resistance (MDR), represents a major obstacle to chemotherapy. Expression of P-glycoprotein (P-gp) in MCF7mdr and MCF7R resistant cells was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis. MCF7R, but not the MDR1 gene-transfected MCF7mdr cells, expressed multidrug-related protein (MRP) concomitantly. Efficacy of an MDR modulator, designated as Servier 9788 (S9788), was estimated by doxorubicin (Dox) sensitization, Dox incorporation, and functional rhodamine 123 assay on MCF7 cell lines. Results showed that S9788 modulates the P-gp-associated MDR of MCF7mdr cells as well as the Multidrug-related protein-associated MDR of MCF7R cells.
机译:对多种天然药物的固有或获得性耐药性(称为多重耐药性(MDR))是化疗的主要障碍。通过逆转录聚合酶链反应(RT-PCR)和蛋白质印迹分析检测MCF7mdr和MCF7R耐药细胞中P糖蛋白(P-gp)的表达。 MCF7R而非MDR1基因转染的MCF7mdr细胞同时表达多药相关蛋白(MRP)。 MDR调节剂(称为Servier 9788(S9788))的功效通过阿霉素(Dox)致敏,Dox掺入和功能性罗丹明123测定法在MCF7细胞系上评估。结果表明,S9788调节MCF7mdr细胞的P-gp相关MDR以及MCF7R细胞的多药相关蛋白相关MDR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号